Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro
| Image |  |
|---|---|
| Description | scientific article published in January 2005 |
| Author/s |
author: Simon P Robinson |
| Publication date | January 1, 2005 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |